to attack their cancer. When Tom and Kari found out about the trial, they didn’t hesitate to enroll Emily. “Some parents would think, ‘I’m not sure I want my child to be a science experiment,’ but trying these experimental studies is what leads to breakthroughs,” said Tom.
Emily was the first child to receive CAR T-cell therapy, and in May 2012—23 days after treatment—there was no cancer in her body. It has never returned. Inspired by their daughter’s recovery and the potential for this research to help other children, the Whiteheads launched the Emily Whitehead Foundation.
theNCI Did big pharma let yall start studying the benefits of colloidal silver yet?
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: